Biophotonics Market - Global Industry Analysis

Biophotonics Market By End-use (Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical.) By Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 02-Jun-2021 Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-145 Status : Published

The global Biophotonics market accounted for USD 37.4 Billion in 2020 and is expected to reach USD 88.1 Billion by 2028, growing at a CAGR of around 8.3% between 2021 and 2028.

Description

Market Overview     

The global Biophotonics market accounted for USD 37.4 Billion in 2020 and is expected to reach USD 88.1 Billion by 2028, growing at a CAGR of around 8.3% between 2021 and 2028.    

Biophotonics generates and harnessing light to visualize, detect, and manipulate biological materials. It is used to understand the internal functioning of cells and tissues in living organisms.

Researchers have found that biophotonics procedure such as Raman spectroscopy, two-photon fluorescence spectroscopy, optical coherence tomography, one-photon fluorescence spectroscopy, and confocal reflection spectroscopy can help in identifying tumors at early phases, monitoring metabolic products & biomarkers, and examining eye fundus. The move is forecast to boost biophotonics market growth in the near future.

COVID-19 Impact Analysis  

The global Biophotonics market has witnessed a slight decline in the sales for short term to the lockdown enforcement placed by governments in order to contain COVID spreading. The restrictions imposed by various nations to contain COVID had stopped the production resulting in a disruption across the whole supply chain. However, the global markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year.  The significant decrease in the global Biophotonics market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.

Growth Factors

“Large-scale use of photonic parts in healthcare equipment to obtain greater accuracy and sensitivity will boost the growth of biophotonics market over the coming years,” says the author of this study. Apart from this, rapidly increasing geriatric population and rising incidences of chronic ailments will lead to more demand for biophotonics over the forthcoming years. In addition to this, favorable government policies and prominent application of IT in the healthcare sector will further boost the biophotonics market trends.

Escalating costs of biophotonics-based equipment along with the intricacies associated with the biophotonics technology, however, are likely to hinder the biophotonics market evolution over the next few years. Nevertheless, substantial advancements in the technology over the past few years and its rapid acceptance across the medical industry are anticipated to harvest new growth avenues for biophotonics market, normalizing the impact of hindrances on the biophotonics market, reports the study.

Report Scope:  

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview  

Biophotonics finds wide applications in dentistry and medical sectors, owing to its ability to effectively diagnose & treat diseases.  Massive applications in biosensors, microscopy, surface imaging, see through mapping, light therapy, inside imaging, and spectro molecular will elevate the biophotonics market expansion over the few years span.

Key Market Players & Competitive Landscape

Some of the major players of global Biophotonics market includes Becton, Dickinson and Company, Carl Zeiss AG, FEI Company, Hamamatsu Photonics K.K., Olympus Corporation, and Andor Technology Ltd.

The global Biophotonics Market is segmented as follows:

By End-uses

  • Test & Components
  • Medical Therapeutics
  • Medical Diagnostics
  • Non-Medical

By Applications

  • See-Through Imaging
  • Microscopy
  • Inside Imaging
  • Spectro Molecular
  • Light Therapy
  • Surface Imaging
  • Biosensors

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By End-use
        • 2.1.1.2. Market Attractiveness Analysis, By Application
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Biophotonics Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Biophotonics Market – End-use Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By End-use, 2020 & 2028
    • 4.2. Test & Components
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Medical Therapeutics
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Medical Diagnostics
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Non-medical
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Biophotonics Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. See-Through Imaging
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Microscopy
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Inside Imaging
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Spectro Mulecular
      • 5.5.1. Market Size and Forecast, By Region (USD Billion)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Light Therapy
      • 5.6.1. Market Size and Forecast, By Region (USD Billion)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Surface Imaging
      • 5.7.1. Market Size and Forecast, By Region (USD Billion)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.8. Biosensors
      • 5.8.1. Market Size and Forecast, By Region (USD Billion)
      • 5.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By End-use, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By End-use, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Application, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By End-use, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By Application, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By End-use, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By Application, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By End-use, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By End-use, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By Application, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By End-use, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By Application, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By End-use, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By Application, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By End-use, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By Application, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By End-use, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By Application, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By End-use, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By End-use, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By End-use, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By Application, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By End-use, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By End-use, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By Application, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By End-use, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By End-use, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By End-use, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By End-use, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By End-use, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By End-use, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By End-use, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By End-use, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By End-use, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By End-use, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By End-use, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 7: Biophotonics Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Biophotonics Market: Company Market Share, 2019
      • 8.1.2. Global Biophotonics Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Biophotonics Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Biophotonics Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Becton
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Dickinson and Company
    • 9.3. Carl Zeiss AG
    • 9.4. FEI Company
    • 9.5. Hamamatsu Photonics K.K
    • 9.6. Olympus Corporation
    • 9.7. Andor Technology Ltd
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By End-use
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Biophotonics Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By End-use, 2020 & 2028 
FIG NO. 7. Global Biophotonics Market for Test & Components, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Biophotonics Market for Test & Components, By Country, 2020 & 2028
FIG NO. 9. Global Biophotonics Market for Medical Therapeutics, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Biophotonics Market for Medical Therapeutics, By Country, 2020 & 2028
FIG NO. 9. Global Biophotonics Market for Medical Diagnostics, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Biophotonics Market for Medical Diagnostics, By Country, 2020 & 2028
FIG NO. 11. Global Biophotonics Market for Non-Medical, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Biophotonics Market for Non-Medical, By Country, 2020 & 2028
FIG NO. 13. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 14. Global Biophotonics Market for See-Through Imaging, Revenue (USD Billion) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Biophotonics Market for See-Through Imaging, By Country, 2020 & 2028 
FIG NO. 16. Global Biophotonics Market for Microscopy, Revenue (USD Billion) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Biophotonics Market for Microscopy, By Country, 2020 & 2028
FIG NO. 18. Global Biophotonics Market for Inside Imaging, Revenue (USD Billion) 2016 – 2028 
FIG NO. 19. Comparative Revenue Analysis of Biophotonics Market for Inside Imaging, By Country, 2020 & 2028
FIG NO. 20. Global Biophotonics Market for Spectro Molecular, Revenue (USD Billion) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Biophotonics Market for Spectro Molecular, By Country, 2020 & 2028
FIG NO. 22. Global Biophotonics Market for Light Therapy, Revenue (USD Billion) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Biophotonics Market for Light Therapy, By Country, 2020 & 2028
FIG NO. 24. Global Biophotonics Market for Surface Imaging, Revenue (USD Billion) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Biophotonics Market for Surface Imaging, By Country, 2020 & 2028
FIG NO. 26. Global Biophotonics Market for Biosensors, Revenue (USD Billion) 2016 – 2028
FIG NO. 27. Comparative Revenue Analysis of Biophotonics Market for Biosensors, By Country, 2020 & 2028
FIG NO. 28. Global Biophotonics Market Revenue Share, By Region, 2020 & 2028
FIG NO. 29. North America Biophotonics Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 30. Porter’s Five Forces Analysis for Global Biophotonics Market
FIG NO. 23. PEST Analysis for Global Biophotonics Market
FIG NO. 31. Pricing Analysis for Global Biophotonics Market
FIG NO. 32. Value Chain Analysis for Global Biophotonics Market
FIG NO. 33. Company Share Analysis, 2019
FIG NO. 34. Radar Determinant Chart, 2019
FIG NO. 35. Company Strategic Developments – Heat Map Analysis
FIG NO. 36. Becton Business Segment Revenue Share, 2020 (%)
FIG NO. 37. Becton Geographical Segment Revenue Share, 2020 (%)
FIG NO. 38. Market Channels
FIG NO. 39. Marketing Channel Development Trend
FIG NO. 40. Growth in World Gross Product, 2008-2018
FIG NO. 41. Research Methodology – Detailed View
FIG NO. 42. Research Methodology


Table Of Tables

List of Tables 

TABLE NO. 1. Global Biophotonics Market: Snapshot
TABLE NO. 2. Quarterly Biophotonics Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Biophotonics Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Biophotonics Market for Test & Components, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Biophotonics Market for Medical Therapeutics, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Biophotonics Market for Medical Diagnostics, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Biophotonics Market for Non-Medical, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Biophotonics Market for See-Through Imaging, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11 Global Biophotonics Market for Microscopy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Biophotonics Market for Inside Imaging, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Biophotonics Market for Spectro Molecular, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14. Global Biophotonics Market for Light Therapy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Biophotonics Market for Surface Imaging, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. Global Biophotonics Market for Biosensors, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 17. Global Biophotonics Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 18. North America Biophotonics Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 19. North America Biophotonics Market Revenue, By End-use, 2016 – 2028 (USD Billion)
TABLE NO. 20. North America Biophotonics Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 21. U.S. Biophotonics Market Revenue, By End-use, 2016 – 2028 (USD Billion)
TABLE NO. 22. U.S. Biophotonics Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 23. Canada Biophotonics Market Revenue, By End-use, 2016 – 2028 (USD Billion)
TABLE NO. 24. Canada Biophotonics Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 25. Mexico Biophotonics Market Revenue, By End-use, 2016 – 2028 (USD Billion)
TABLE NO. 26. Mexico Biophotonics Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 27. Drivers for the Biophotonics Market: Impact Analysis
TABLE NO. 28. Restraints for the Biophotonics Market: Impact Analysis
TABLE NO. 29. Major Buyers of Biophotonics
TABLE NO. 30. Distributors/Traders List of Biophotonics
TABLE NO. 31. Global Biophotonics Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 32: Global Biophotonics Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   


 

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Biophotonics market. Zion Research has collected and analyzed key data belong to the global Biophotonics market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined afterconducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Biophotonics across the world has been calculated through primary and secondary research.

Zion Research employs combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include, STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assistedin validation of findings from secondary research and to understand key trends in the Biophotonics industry. Primary research makes up major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Biophotonics market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Biophotonics is the combination of biological materials and light which integrates lasers, photonics, biotechnology and nanotechnology. Biophotonics is applied in dentistry and medicine for diagnosis and treatment of diseases. Biophotonics uses light beams and forms of energy to diagnose and monitor medical conditions. Biophotonics plays an important role in dentistry for the early detection of diseases.

Increasing geriatric population coupled with rising frequency of chronic diseases are major driving factors for biophotonics market. Moreover, increasing government initiatives and incorporation of IT in the healthcare sectors is expected to have positive impact on the biophotonics market. The increase in the number of photonic components in the healthcare instruments for higher accuracy & sensitivity andvalue improvement is anticipated to drive the market growth in the years to come.However, high price of biophotonics-based instruments coupled with complexity of the biophotonics technology may curb the market growth in the near future. Nevertheless, the significant technological advancements over the decade and their adoption in the medical sector are expected to open up new growth opportunities within the forecast period.

Global Biophotonics Market

The application segments for biophotonics market are see-through imaging, microscopy, inside imaging, spectro molecular, light therapy, surface imaging, and biosensors. In 2015, see-through imaging was sharing the largest part of revenue due to strong demand for radical non-invasive surgical procedures in medical sectors, such as brain imaging, cardiology, neurology, and oncology. Light therapy is expected to witness the fastest growth in the years to come

Test & components, medical therapeutics, medical diagnostics, and non-medical are the key end-users in the biophotonics market. Medical diagnostics accounted for the largest share of revenue, as a result of increasing adoption by different end-users which include healthcare providers, research laboratories, and instrument manufacturers.Non-medical is another key outlet of biophotonics market and is expected to experienced strong growth in the near future. This growth is mainly due to its environmental screening and monitoring capabilities. Moreover, test & components and medical therapeutics are projected to witness significant growth within the forecast period.

In terms of geography, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa. North America dominated this market with the largest share of biophotonics market as a result of surging R&D initiatives and accessibility to the excellent infrastructure coupled with the high investments in the healthcare sector.Europe accounted for a profitable share in terms of revenue in 2015owing to various ongoing development activities in the medical sector. However, Asia pacific is anticipated to witness robust growth in the years to come on account of the developing economic status and rising demand for the R&D projects. Latin America and the Middle East & Africa is expected to show significant growth in the coming years. This growth is mainly due to increase awareness and demand for biologics and improvement in health care infrastructure.

The key market players comprise Carl Zeiss,LumenisLtd., Hamamatsu Photonics K.K., BD (Becton, Dickinson and Company), Andor Technology Ltd, Olympus Corporation,Perkinelmer, Inc., Affymetrix Inc.,FEI Company and Olympus America.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Biophotonics Market was valued at USD 37.4 billion in 2020.

The global Biophotonics Market is expected to reach USD 88.1 billion by 2028, growing at a CAGR of 11.4% between 2021 to 2028.

Some of the key factors driving the global Biophotonics Market growth are Emergence of nanotechnology leading to the development of biophotonics, Development in Biosensors leading to the development of biophotonics market, and  Availability of funds for research and development.

North America has been leading the worldwide biophotonics market and is anticipated to continue on the dominant position in the years to come, states the market study. Mounting investments in the medical sector, outstanding infrastructural development, and increase in research & development activities are the key factors that have contributed towards the dominance of the North America biophotonics market.

Some of the major players of global Biophotonics market includes Becton, Dickinson and Company, Carl Zeiss AG, FEI Company, Hamamatsu Photonics K.K., Olympus Corporation, and Andor Technology Ltd.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed